SBIR basics
Who owns the IP in an SBIR award? Data rights explained
SBIR data rights, Bayh-Dole obligations and what the government can and cannot do with your technology, explained for US startup founders and investors.
You keep the IP
The single most common reason founders hesitate over SBIR funding is a belief that the government takes ownership of the technology. It does not. Under the Bayh-Dole Act, the small business retains title to any subject invention conceived or first reduced to practice under a federal award, provided you meet the disclosure and election requirements on time.
The government receives a non-exclusive, non-transferable, royalty-free licence to practise the invention for government purposes. That is a use right, not ownership, and it does not stop you licensing, selling or raising equity against the same technology.
What SBIR data rights actually protect
Separate from patents, SBIR data rights cover the technical data and software you generate under the award. During the protection period the government may not release or disclose that data outside government, and may not use it to have a competitor reproduce your work.
The protection period now runs for 20 years from award for data generated under an SBIR or STTR funding agreement. Mark the data correctly with the SBIR rights legend in every deliverable and report, because unmarked data can lose its protected status.
The obligations that come with it
Bayh-Dole is a bargain, not a gift. You must disclose each subject invention to the agency within two months of it being reported internally, elect to retain title within two years of disclosure, file a patent application within the statutory window, and include the government support statement in the patent itself.
Miss those deadlines and the agency can request title. In practice, agencies grant extensions far more often than they take title, but the risk is real and entirely avoidable with a simple internal tracking process.
US manufacturing and march-in rights
Products embodying a subject invention that are sold in the United States must be substantially manufactured in the United States, unless you obtain a waiver. Agencies grant waivers where domestic manufacture is not commercially feasible, but plan the conversation early if your supply chain sits overseas.
March-in rights allow an agency to require licensing in narrow circumstances, such as a failure to take effective steps toward practical application. They have never been exercised to force a licence. Investors who raise this concern are usually working from headlines rather than the record.
What this means in a fundraise
Sophisticated investors treat SBIR awards as validation and as balance sheet strength. Non-dilutive capital that funds technical risk reduction leaves more of the company with the founders at Series A, and a competitive federal award is an independent technical review that a term sheet cannot buy.
Diligence will ask three things: are your invention disclosures current, are your deliverables marked with the SBIR legend, and is your subaward or consultant IP flow-down documented. Get those three right and the award strengthens the round rather than complicating it.
Get the paperwork right from day one
Most IP problems in SBIR-funded companies are administrative, not legal. They come from missed disclosure dates, unmarked reports and university subawards where rights were never allocated in writing.
Our US team builds the compliance mechanics into the application itself, so the rights position is clean before the first payment lands. Book a free consultation if you want an outside view of how your current award or draft handles IP.
Ready to turn this into a funded proposal?
Book a free 30-minute consultation with a senior grant consultant. We will check your eligibility, match you to the right program, and map out your submission timeline.
Learn more about our approach